Need professional-grade analysis? Visit stockanalysis.com
$33.52B
12.67
2,162
1.92%
Price Chart
Risk-Adjusted Performance
Giant Biogene Holding Co Ltd (2367) Price Performance
Giant Biogene Holding Co Ltd (2367) trades on Hong Kong Stock Exchange in HKD. The company is classified in the Consumer Defensive sector under the Household & Personal Products industry. The stock currently trades at HKD29.68, down 3.32% from the previous close.
Over the past year, 2367 has traded between a low of HKD29.22 and a high of HKD83.95. The stock has lost 55.9% over this period. It is currently 64.6% below its 52-week high.
Giant Biogene Holding Co Ltd has a market capitalization of $33.52B, with a price-to-earnings ratio of 12.67 and a dividend yield of 1.92%.
About Giant Biogene Holding Co Ltd
Giant Biogene Holding Co., Ltd., an investment holding company, designs, develops, manufactures, and sells skin treatment products with recombinant collagen in the People's Republic of China. It also develops and manufactures rare ginsenosides technology-based functional food products; and offers medical devices. The company provides its functional skincare products, medical dressings, and functional food products primarily under the Comfy, Collgene, Ke Yu, and SKIGIN brands. Giant Biogene Holding Co., Ltd. was founded in 2000 and is headquartered in Xi'an, the People's Republic of China.
Company Info
- Sector
- Consumer Defensive
- Industry
- Household & Personal Products
- Exchange
- Hong Kong Stock Exchange
- Currency
- HKD
- Country
- Hong Kong
Financial Metrics
- Revenue (TTM)
- $6.11B
- EBITDA
- $2.61B
- Profit Margin
- 37.00%
- EPS (TTM)
- 2.22
- Book Value
- 9.64
Technical Indicators
- 52 Week High
- HK$86.13
- 52 Week Low
- HK$28.96
- 50 Day MA
- HK$33.07
- 200 Day MA
- HK$45.29
- Beta
- 0.49
Valuation
- Trailing P/E
- 12.67
- Forward P/E
- 10.16
- Price/Sales
- 5.49
- Price/Book
- 3.16
- Enterprise Value
- $22.90B